The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
IN VITRO DIAGNOSTICS Aria Diagnostics Inc. Oversubscribed Series C leads to $52.7mm for Aria Diagnostics Molecular diagnostics company Ariosa Diagnostics Inc. (formerly Tandem Diagnostics) has